Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems ...

Pomerantz LLP announces a class action lawsuit filed against 3D Systems Corporation and certain officers for alleged securities law violations during August 2024 to May 2025.

The lawsuit claims 3D Systems misled investors about its business resilience amid industry challenges and failed to properly disclose the negative impact of updated milestone criteria in its Regenerative Medicine Program partnership with United Therapeutics. The company's stock dropped significantly after disappointing quarterly results that missed analyst expectations and revealed accounting estimate changes that reduced revenue by $9 million.

• Investors who purchased 3D Systems securities between August 13, 2024, and May 12, 2025, have until August 12, 2025, to join the class action
• Stock price fell 20.96% to $2.15 after Q4 2024 results and another 26.6% to $1.87 following Q1 2025 earnings
• The company withdrew its full-year 2025 outlook citing prolonged customer spending weakness and macroeconomic uncertainty
• Contact Danielle Peyton at newaction@pomlaw.com or visit www.pomerantzlaw.com for more information about joining the lawsuit